Optic IconOptic Logo
|
SearchCollectionsBenchmarks
Product

AJU-S56

Aliases
AJU-S56 5%, Test Group

2 clinical trials

1 indication

Indication
Dry Eye Syndrome
Clinical trial
The Purpose of This Clinical Study is to Prove That the Test Drug (AJU-S56 5%) is Superior to the Control Drug After 24 Weeks of Administration to Patients Who Have Moderate or Severe Dry Eye Syndrome
Status: Recruiting, Estimated PCD: 2024-05-01
Clinical trial
A Phase 2 Multicenter, Randomized, Double-blinded, Placebo-controlled Trial to Evaluate the Efficacy and Safety of AJU-S56 in Patients With Dry Eye Disease
Status: Completed, Estimated PCD: 2022-06-14